‪Eskandar Parvaz‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	77	44
h-index	3	3
i10-index	2	2

0

16

8

2015201620172018201920202021202220235 6 7 15 6 14 9 9 6

Co-authors

Maani BeigyMD-MPH Tehran University of Medical SciencesVerified email at alumnus.tums.ac.ir

Eskandar Parvaz

Eskandar Parvaz

Tehran University of Medical Sciences

Verified email at razi.tums.ac.ir

Clinical Biochemistry


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance? P Shabani, H Naeimi Khaledi, M Beigy, S Emamgholipour, E Parvaz, ... PLoS One 10 (3), e0118650, 2015	38	2015
The mRNA expression and circulating levels of visfatin and their correlation with coronary artery disease severity and 25-hydroxyvitamin D R Fadaei, E Parvaz, S Emamgholipour, N Moradi, A Vatannejad, M Najafi, ... Hormone and metabolic research 48 (04), 269-274, 2016	31	2016
Circulating levels of IL-35 and gene expression of FoxP3 in coronary artery disease: Is there any interplay between them and 25-hydroxyvitamin D3? H Shateri, R Fadaei, M Najafi, A Vatannejad, M Teimouri, F Zali, ... Clinical Laboratory 64 (4), 2018	8	2018

The system can't perform the operation now. Try again later.

Articles 1–3